Biotech Values

[mcbio]

I just saw the good news!! This is what I have been waiting for as the chronic pain market is the real driver of Relistor sales. I don't think the traders who have been manipulating the stock price will go away, but the lower level of the trading range has been raised. This is a really nice Christmas present for longs, especially those of us who have suffered with PGNX for a very long time.

Yep, it's great news for us PGNX longs. A little bit of a pop in the stock but I won't be selling at these levels as I'm willing to hold to see if Relistor gets approved in the chronic, non-cancer setting (both the subQ version and this oral version). I'm willing to do this as I don't see PGNX as a one-trick pony anymore given the clinical data to date with the PSMA ADC for prostate cancer (#msg-67357499 ). I think that drug could turn out to be a value driver down the road for PGNX all on its own.